Faculté de médecine Faculté de médecine

Isabella Eckerle

Research funding & Projects

Research funding and projects:

  • Swiss National Foundation (SNF), Project: "Arms race between viral evolution and population immunity – Understanding the impact of antibody pressure on SARS-CoV-2 variants and human endemic coronaviruses"
  • Carigest Foundation, Project: “Establishment of an in vitro model of polarized primary human airway epithelial cells from children for the study of viral respiratory infections” .
  • Horizon 2020, European Union, Project: “European Clinical Research Alliance on Infectious Diseases – ECRAID-Base.
  • Swiss National Foundation (SNF) National Research Program (NRP) 78 "Covid-19" “Large-scale serological profiling of SARS-CoV-2 and related human CoVs with high-throughput microfluidic nano-immunoassays”,
  • Co-application with Sebastian Maerkl, École polytechnique fédérale de Lausanne (EPFL).
  • Swiss National Foundation (SNF), Special call on coronaviruses, Project: “Phenotypic characterization of a SARS-CoV-2 clinical strain biobank and risk assessment of evolving virus variants,
  • Swiss National Foundation (SNF), Special call on coronaviruses Project: “Real-time pandemic functional characterization of SARS-CoV-2”.
  • Co-application with Volker Thiel and Ronald Dijkman (Institute of Virology and Immunologie, Bern)
  • Collaborating laboratory for the Foundation for Innovative Diagnostics (FIND): “Support for accurate 2019-nCoV diagnostics”.
  • Fondation privée HUG: Rapid response support for SARS-CoV-2.
  • Fondation Pictet, Project: “COVID-19, le nouveau défi du Centre de maladies virales émergentes - Understanding transmission & risk factors for COVID-19 in primary cell culture models”.
  • Fondation Ernst et Lucie Schmidheiny, Project: „Assessment of host-switching capacity of newly identified bat filoviruses through single amino acid change in the spike glycoprotein“.

Isabella Eckerle is also part of the following initiatives:

  • High-Level European Expert Group for Covid19 and Monkeypox stabilisation, WHO EURO.
  • Expert on the panel on pandemic respiratory diseases at the Robert Koch Institute (RKI) in Germany.
  • Member of the joint ECDC/WHO Euro SARS-CoV-2 Virus Characterization Working Group .
  • Scientific advisory board for the WHO BioHub, Spiez Laboratory, Switzerland .
  • Invited expert at the World Health Organization, Global research and innovation forum: towards a research roadmap for the 2019 novel Coronavirus, R&D Blueprint Initiative (11-12 February 2020).
  • Part of the expert group on virus’ natural history and transmission.
  • World Health Organization, Target Product Profile Group: COVID-19 Target product profiles for priority diagnostics to support response to the COVID-19 pandemic v.1.0, 29 September 2020, https://www.who.int/publications/m/item/covid-19-target-product-profiles-for-priority-diagnostics-to-support-response-to-the-covid-19-pandemic-v.0.1.
  • World Health Organization: Temporary Advisor to the WHO for the Expert Consultation on mother-to-child transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (Oktober 2020).